Updates from the Cardiolyse team on product, clinical research, partnerships and events.
HeartEye and Cardiolyse combine a wire-free, medical-grade 12-lead ECG device with automated ECG interpretation, to bring full cardiac checks outside the hospital.
Read the article
In 953 participants at University Medical Center Mainz, the Cardiolyse RoHD score was the most predictive of 180 ECG markers for worsening heart failure and death — independently of NT-proBNP and the MAGGIC score.
Read the article
Cardiolyse ECG analytics runs inside MedicubeX autonomous eHealth Stations, turning a routine self-service check into heart-health risk profiling. Live in Finland, Germany, the UK, Latvia and Estonia.
Read the article
Forty patients followed for twelve weeks at home after atrial ablation, with the arrhythmology and electrophysiology unit in Cotignola, Italy. Clinicians and patients gave positive feedback, and their input shaped our roadmap.
Read the article
Taken through TheHill Oxford’s formal pipeline process to pilot stage at the John Radcliffe Hospital, working with one of the leading cardiologists at Oxford University Hospitals.
Read the article
A European pre-commercial procurement for chronic care in rural areas. Cardiolyse brought heart-health screening analytics for home ECG recordings on a Beurer device, across three countries.
Read the article